Emblem Medicaid 4th Quarter Formulary Updates

Size: px
Start display at page:

Download "Emblem Medicaid 4th Quarter Formulary Updates"

Transcription

1 abacavir 20 mg/ml solution Added to Formulary (generic) with Quantity Limits 12/1/2017 abacavir 300 mg tablet Added Quantity Limits 10/1/2017 abacavir-lamivudine mg Added Quantity Limits 10/1/2017 abacavir-lamivudine-zidov tab Added Quantity Limits 10/1/2017 acetaminoph-caff-dihydrocodein Removed from Formulary (Obsolete Drug) 10/1/2017 AFLURIA SYRINGE Removed from Formulary (Obsolete Drug) 10/1/2017 AFLURIA VIAL Removed from Formulary (Obsolete Drug) 10/1/2017 AFLURIA SYRINGE Added to Formulary (BRAND) 10/1/2017 AFLURIA VIAL Added to Formulary (BRAND) 10/1/2017 AFLURIA QUAD SYRINGE Added to Formulary (BRAND) 10/1/2017 AFLURIA QUAD VIAL Added to Formulary (BRAND) 10/1/2017 akorn balanced salt soln Removed from Formulary (Obsolete Drug) 10/1/2017 ALBENZA 200 MG TABLET Added Quantity Limits 10/1/2017 ALINIA 100 MG/5 ML SUSPENSION Added Quantity Limits 10/1/2017 ALINIA 500 MG TABLET Added Quantity Limits 10/1/2017 APTIVUS 100 MG/ML SOLUTION Added Quantity Limits 10/1/2017 APTIVUS 250 MG CAPSULE Added Quantity Limits 10/1/2017 aspirin ec 975 mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 ATRIPLA TABLET Added Quantity Limits 10/1/2017 AVITENE SHEET 35MMX35MM Added to Formulary (BRAND) 10/1/2017 AVITENE SHEET 70MMX35MM Added to Formulary (BRAND) 10/1/2017 AXIRON 30 MG/ACTUATION SOLN Removed from Formulary (Generic Available) 10/1/2017 benzoyl peroxide 5.3% foam Added to Formulary (generic) 10/1/2017 bexarotene 75 mg capsule Added Prior Authorization 11/24/2017 budeprion sr 150 mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 butalb-acetamin-caff Removed from Formulary (Obsolete Drug) 10/1/2017 butalb-acetaminoph-caff-codein Added to Formulary (generic) 10/1/2017 butalb-aspirin-caffe Added to Formulary (generic) 10/1/2017 BYDUREON BCISE 2 MG AUTOINJECT Added to Formulary (BRAND) with Prior Authorization 12/1/2017 CALCIUM 500-VIT D3 600 CAPLET Added to Formulary (BRAND) 12/1/2017 choice-ob + dha combo pack Removed from Formulary (Obsolete Drug) 10/1/2017 choice-tabs tablet Removed from Formulary (Obsolete Drug) 10/1/2017 ciclodan 0.77% cream Added Quantity Limits 10/1/2017 ciclopirox 0.77% cream Added Quantity Limits 10/1/2017 ciclopirox 0.77% gel Added Quantity Limits 10/1/2017 ciclopirox 0.77% topical susp Added Quantity Limits 10/1/2017 ciclopirox 1% shampoo Added Quantity Limits 10/1/2017 clotrimazole 1% cream Added Quantity Limits 10/1/2017 clotrimazole 1% solution Added Quantity Limits 10/1/2017 clotrimazole-betamethasone crm Added Quantity Limits 10/1/2017 clotrimazole-betamethasone lot Added Quantity Limits 10/1/2017 COMBIVIR TABLET Added Quantity Limits 10/1/2017 COMPLERA TABLET Added Quantity Limits 10/1/2017 CRIXIVAN 200 MG CAPSULE Added Quantity Limits 10/1/2017 CRIXIVAN 400 MG CAPSULE Added Quantity Limits 10/1/2017 DESCOVY MG TABLET Added Quantity Limits 10/1/2017 didanosine dr 125 mg capsule Added Quantity Limits 10/1/2017 didanosine dr 200 mg capsule Added Quantity Limits 10/1/2017

2 didanosine dr 250 mg capsule Added Quantity Limits 10/1/2017 didanosine dr 400 mg capsule Added Quantity Limits 10/1/2017 difil-g 400 tablet Removed from Formulary (Obsolete Drug) 10/1/2017 dilt-cd 120 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 dilt-cd 180 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 dilt-cd 240 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 dilt-cd er 300 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 diltzac er 120 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 diltzac er 180 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 diltzac er 240 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 diltzac er 300 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 diltzac er 360 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 dologesic capsule Removed from Formulary (Obsolete Drug) 12/1/2017 doxepin 5% cream Added Quantity Limits 10/1/2017 doxepin 5% cream Added Prior Authorization 11/1/2017 econazole nitrate 1% cream Added Quantity Limits 10/1/2017 EDURANT 25 MG TABLET Added Quantity Limits 10/1/2017 EMEND 125 MG CAPSULE Removed from Formulary (Generic Available) 12/1/2017 EMTRIVA 10 MG/ML SOLUTION Added Quantity Limits 10/1/2017 EMTRIVA 200 MG CAPSULE Added Quantity Limits 10/1/2017 EMVERM 100 MG TABLET CHEW Added Quantity Limits 10/1/2017 ENBREL 50 MG/ML MINI CARTRIDGE Added to Formulary (BRAND) with Prior Authorization and Q 12/1/2017 ENDO-AVITENE 10MM SHEET Added to Formulary (BRAND) 10/1/2017 endur-acin er 500 mg tablet Added to Formulary (generic) 12/1/2017 EPIVIR 10 MG/ML ORAL SOLN Added Quantity Limits 10/1/2017 EPIVIR 150 MG TABLET Added Quantity Limits 10/1/2017 EPIVIR 300 MG TABLET Added Quantity Limits 10/1/2017 EPZICOM TABLET Added Quantity Limits 10/1/2017 ergocalciferol 1.25 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017 erythromycin-sulfisox susp Removed from Formulary (Obsolete Drug) 10/1/2017 estradiol 10 mcg vaginal insrt Added to Formulary (generic) 10/1/2017 ethynodiol-eth estra 1mg-35mcg Added to Formulary (generic) with Quantity Limits 12/1/2017 EVOTAZ 300 MG-150 MG TABLET Added Quantity Limits 10/1/2017 E-Z SPACER PEDSPAK KIT Removed from Formulary (Obsolete Drug) 10/1/2017 FISH OIL 1;200 MG SOFTGEL Added to Formulary (BRAND) 12/1/2017 FLEXIFLO QUANTUM PUMP SET Removed from Formulary (Obsolete Drug) 10/1/2017 FLUAD SYRINGE Added to Formulary (BRAND) 10/1/2017 FLUARIX QUAD SYRINGE Added to Formulary (BRAND) 10/1/2017 FLUBLOK VIAL Added to Formulary (BRAND) 10/1/2017 FLUBLOK QUAD SYRINGE Added to Formulary (BRAND) 10/1/2017 FLUCELVAX QUAD SYR Added to Formulary (BRAND) 10/1/2017 FLUCELVAX QUAD VIAL Added to Formulary (BRAND) 10/1/2017 FLULAVAL QUAD SYR Added to Formulary (BRAND) 10/1/2017 FLULAVAL QUAD VIAL Added to Formulary (BRAND) 10/1/2017 FLUMIST NASAL VACCINE Removed from Formulary (Obsolete Drug) 10/1/2017 fluoxetine hcl 60 mg tablet Added to Formulary (generic) 12/1/2017 FLUVIRIN SYRINGE Added to Formulary (BRAND) 10/1/2017 FLUVIRIN VIAL Added to Formulary (BRAND) 10/1/2017

3 FLUZONE SYRINGE Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE VIAL Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE VIAL (PF) Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE HIGH-DOSE SYR Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE HIGH-DOSE SYR Added to Formulary (BRAND) 10/1/2017 FLUZONE INTRADER SYR Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE INTRADERM QUAD Added to Formulary (BRAND) 10/1/2017 FLUZONE PEDI SYRINGE Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE QUAD SYRINGE Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE QUAD VIAL Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE QUAD SYRINGE Added to Formulary (BRAND) 10/1/2017 FLUZONE QUAD VIAL Added to Formulary (BRAND) 10/1/2017 FLUZONE QUAD VIAL Added to Formulary (BRAND) 10/1/2017 FLUZONE QUAD PEDI SYR Removed from Formulary (Obsolete Drug) 10/1/2017 FLUZONE QUAD PEDI SYR Added to Formulary (BRAND) 10/1/2017 folcal dha capsule Removed from Formulary (Obsolete Drug) 10/1/2017 folcaps omega-3 capsule Removed from Formulary (Obsolete Drug) 10/1/2017 fosamprenavir 700 mg tablet Added to Formulary (generic) with Quantity Limits 12/1/2017 FUZEON 90 MG VIAL Added Quantity Limits 10/1/2017 GENVOYA TABLET Added Quantity Limits 10/1/2017 halonate combo pack Removed from Formulary (Obsolete Drug) 10/1/2017 halonate pac combo pack Removed from Formulary (Obsolete Drug) 10/1/2017 HUMALOG JR 100 UNIT/ML KWIKPEN Added to Formulary (BRAND) 12/1/2017 HUMULIN PEN Removed from Formulary (Obsolete Drug) 10/1/2017 HUMULIN N 100 UNITS/ML PEN Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetamin /15 Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminoph Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminoph Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminoph Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminophen Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminophn Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminophn Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminophn Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodon-acetaminophn Removed from Formulary (Obsolete Drug) 10/1/2017 hydrocodone-acetamin 5-334/10 Removed from Formulary (Obsolete Drug) 10/1/2017 INFERGEN 15 MCG/0.5 ML VIAL Removed from Formulary (Obsolete Drug) 10/1/2017 INFERGEN 9 MCG/0.3 ML VIAL Removed from Formulary (Obsolete Drug) 10/1/2017 INTELENCE 100 MG TABLET Added Quantity Limits 10/1/2017 INTELENCE 200 MG TABLET Added Quantity Limits 10/1/2017 INTELENCE 25 MG TABLET Added Quantity Limits 10/1/2017 INTUNIV ER 1 MG TABLET Removed from Formulary (Generic Available) 10/1/2017 INTUNIV ER 2 MG TABLET Removed from Formulary (Generic Available) 10/1/2017 INTUNIV ER 3 MG TABLET Removed from Formulary (Generic Available) 10/1/2017 INTUNIV ER 4 MG TABLET Removed from Formulary (Generic Available) 10/1/2017 INVIRASE 200 MG CAPSULE Added Quantity Limits 10/1/2017 INVIRASE 500 MG TABLET Added Quantity Limits 10/1/2017 ISENTRESS 100 MG POWDER PACKET Added Quantity Limits 10/1/2017 ISENTRESS 100 MG TABLET CHEW Added Quantity Limits 10/1/2017

4 ISENTRESS 25 MG TABLET CHEW Added Quantity Limits 10/1/2017 ISENTRESS 400 MG TABLET Added Quantity Limits 10/1/2017 ISENTRESS HD 600 MG TABLET Added to Formulary (BRAND) with Quantity Limits 10/1/2017 isomethept-caff-acetaminoph tb Removed from Formulary (Obsolete Drug) 10/1/2017 ivermectin 3 mg tablet Added Quantity Limits 10/1/2017 JADENU SPRINKLE 180 MG GRANULE Added to Formulary (BRAND) with Prior Authorization 10/1/2017 JADENU SPRINKLE 360 MG GRANULE Added to Formulary (BRAND) with Prior Authorization 10/1/2017 JADENU SPRINKLE 90 MG GRANULE Added to Formulary (BRAND) with Prior Authorization 10/1/2017 KALETRA MG TABLET Added Quantity Limits 10/1/2017 KALETRA MG TABLET Added Quantity Limits 10/1/2017 KALETRA 80 MG-20 MG/ML SOLN Added to Formulary (BRAND) with Quantity Limits 10/1/2017 ketoconazole 2% cream Added Quantity Limits 10/1/2017 ketoconazole 2% shampoo Added Quantity Limits 10/1/2017 ketodan 2% foam Added Quantity Limits 10/1/2017 lamivudine 10 mg/ml oral soln Added Quantity Limits 10/1/2017 lamivudine 150 mg tablet Added Quantity Limits 10/1/2017 lamivudine 300 mg tablet Added Quantity Limits 10/1/2017 lamivudine-zidovudine tablet Added Quantity Limits 10/1/2017 levonorg 0.15mg-ee mcg Added to Formulary (generic) with Quantity Limits 12/1/2017 LEXIVA 50 MG/ML SUSPENSION Added Quantity Limits 10/1/2017 LEXIVA 700 MG TABLET Added Quantity Limits 10/1/2017 lopinavir-ritonavir 80-20mg/ml Added Quantity Limits 10/1/2017 lozi-flur 1 mg lozenge Removed from Formulary (Obsolete Drug) 10/1/2017 melphalan 2 mg tablet Added to Formulary (generic) 10/1/2017 m-end wc liquid Removed from Formulary (Obsolete Drug) 10/1/2017 metformin hcl er 500 mg tablet Added Quantity Limits 12/1/2017 metformin hcl er 750 mg tablet Added Quantity Limits 12/1/2017 natal-v rx tablet Removed from Formulary (Obsolete Drug) 10/1/2017 nevirapine 200 mg tablet Added Quantity Limits 10/1/2017 nevirapine 50 mg/5 ml susp Added Quantity Limits 10/1/2017 nevirapine er 100 mg tablet Added Quantity Limits 10/1/2017 nevirapine er 400 mg tablet Added Quantity Limits 10/1/2017 norepinephrine-d5w 4 mg/250 ml Added to Formulary (generic) 10/1/2017 noreth-estrad-fe (21)-75 Added to Formulary (generic) with Quantity Limits 12/1/2017 NORVIR 100 MG SOFTGEL CAP Added Quantity Limits 10/1/2017 NORVIR 100 MG TABLET Added Quantity Limits 10/1/2017 NORVIR 80 MG/ML SOLUTION Added Quantity Limits 10/1/2017 nystatin 100;000 unit/gm cream Added Quantity Limits 10/1/2017 nystatin 100;000 units/gm oint Added Quantity Limits 10/1/2017 ocudox convenience kit Removed from Formulary (Obsolete Drug) 10/1/2017 ODEFSEY TABLET Added Quantity Limits 10/1/2017 ofloxacin 200 mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 olopatadine hcl 0.2% eye drop Added to Formulary (generic) 10/1/2017 ORTHO ALL-FLEX DIAPHRAGM 65MM Removed from Formulary (Obsolete Drug) 10/1/2017 ORTHO TRI-CYCLEN LO TABLET Removed from Formulary (Generic Available) 10/1/2017 oseltamivir 6 mg/ml suspension Added to Formulary (generic) with Quantity Limits 12/1/2017 oxycodon-acetaminophen Removed from Formulary (Obsolete Drug) 10/1/2017 oxycodone-acetaminophen Removed from Formulary (Obsolete Drug) 10/1/2017

5 oxycodone-acetaminophen Removed from Formulary (Obsolete Drug) 10/1/2017 palgic 4 mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 palgic 4 mg/5 ml liquid Removed from Formulary (Obsolete Drug) 10/1/2017 papaverine 150 mg capsule sa Removed from Formulary (Obsolete Drug) 10/1/2017 PATROL ENTERAL PUMP SET Removed from Formulary (Obsolete Drug) 10/1/2017 pnv-first softgel Removed from Formulary (Obsolete Drug) 10/1/2017 pnv-ob with dha combo pack Removed from Formulary (Obsolete Drug) 10/1/2017 POMALYST 1 MG CAPSULE Added Prior Authorization 11/24/2017 POMALYST 2 MG CAPSULE Added Prior Authorization 11/24/2017 POMALYST 3 MG CAPSULE Added Prior Authorization 11/24/2017 POMALYST 4 MG CAPSULE Added Prior Authorization 11/24/2017 pramoxine-hc otic drops Removed from Formulary (Obsolete Drug) 10/1/2017 prena1 chew tablet Removed from Formulary (Obsolete Drug) 10/1/2017 prenaissance harmony dha cmbpk Removed from Formulary (Obsolete Drug) 10/1/2017 PREZCOBIX 800 MG-150 MG TABLET Added Quantity Limits 10/1/2017 PREZISTA 100 MG/ML SUSPENSION Added Quantity Limits 10/1/2017 PREZISTA 150 MG TABLET Added Quantity Limits 10/1/2017 PREZISTA 400 MG TABLET Added Quantity Limits 10/1/2017 PREZISTA 600 MG TABLET Added Quantity Limits 10/1/2017 PREZISTA 75 MG TABLET Added Quantity Limits 10/1/2017 PREZISTA 800 MG TABLET Added Quantity Limits 10/1/2017 promacet mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 PROSTIGMIN 15 MG TABLET Removed from Formulary (Obsolete Drug) 10/1/2017 prudoxin 5% cream Added Quantity Limits 10/1/2017 prudoxin 5% cream Added Prior Authorization 11/1/2017 RESCRIPTOR 100 MG TABLET Added Quantity Limits 10/1/2017 RESCRIPTOR 200 MG TABLET Added Quantity Limits 10/1/2017 RETROVIR 10 MG/ML SYRUP Added Quantity Limits 10/1/2017 RETROVIR 100 MG CAPSULE Added Quantity Limits 10/1/2017 REYATAZ 150 MG CAPSULE Added Quantity Limits 10/1/2017 REYATAZ 200 MG CAPSULE Added Quantity Limits 10/1/2017 REYATAZ 300 MG CAPSULE Added Quantity Limits 10/1/2017 REYATAZ 50 MG POWDER PACKET Added Quantity Limits 10/1/2017 rhinoflex-650 tablet Removed from Formulary (Obsolete Drug) 10/1/2017 roxicet tablet Removed from Formulary (Obsolete Drug) 10/1/2017 SELZENTRY 150 MG TABLET Added Quantity Limits 10/1/2017 SELZENTRY 20 MG/ML ORAL SOLN Added to Formulary (BRAND) with Quantity Limits 10/1/2017 SELZENTRY 25 MG TABLET Added Quantity Limits 10/1/2017 SELZENTRY 300 MG TABLET Added Quantity Limits 10/1/2017 SELZENTRY 75 MG TABLET Added Quantity Limits 10/1/2017 setonet prenatal vitamin Removed from Formulary (Obsolete Drug) 10/1/2017 setonet-ec prenatal vitamins Removed from Formulary (Obsolete Drug) 10/1/2017 sod sulfacetamide-sulfur susp Removed from Formulary (Obsolete Drug) 10/1/2017 stavudine 1 mg/ml solution Added Quantity Limits 10/1/2017 stavudine 15 mg capsule Added Quantity Limits 10/1/2017 stavudine 20 mg capsule Added Quantity Limits 10/1/2017 stavudine 30 mg capsule Added Quantity Limits 10/1/2017 stavudine 40 mg capsule Added Quantity Limits 10/1/2017

6 STERILE TWO-FER NEEDLE Removed from Formulary (Obsolete Drug) 10/1/2017 STRIBILD TABLET Added Quantity Limits 10/1/2017 strovite plus caplet Removed from Formulary (Obsolete Drug) 10/1/2017 SUSTIVA 200 MG CAPSULE Added Quantity Limits 10/1/2017 SUSTIVA 50 MG CAPSULE Added Quantity Limits 10/1/2017 SUSTIVA 600 MG TABLET Added Quantity Limits 10/1/2017 tencon tablet Removed from Formulary (Obsolete Drug) 12/1/2017 tinidazole 500 mg tablet Added Quantity Limits 10/1/2017 TIVICAY 10 MG TABLET Added Quantity Limits 10/1/2017 TIVICAY 25 MG TABLET Added Quantity Limits 10/1/2017 TIVICAY 50 MG TABLET Added Quantity Limits 10/1/2017 TRACLEER 32 MG TABLET FOR SUSP Added to Formulary (BRAND) with Prior Authorization 12/1/2017 trezix capsule Removed from Formulary (Obsolete Drug) 10/1/2017 TRICHLOROACETIC ACID 25% Added to Formulary (BRAND) 10/1/2017 TRICHLOROACETIC ACID 75% Added to Formulary (BRAND) 10/1/2017 triderm 0.5% cream Added to Formulary (generic) 12/1/2017 trinatal ultra tablet Removed from Formulary (Obsolete Drug) 10/1/2017 TRIUMEQ TABLET Added Quantity Limits 10/1/2017 tri-zel tablet Removed from Formulary (Obsolete Drug) 10/1/2017 TRIZIVIR TABLET Added Quantity Limits 10/1/2017 TRUVADA 100 MG-150 MG TABLET Added Quantity Limits 10/1/2017 TRUVADA 133 MG-200 MG TABLET Added Quantity Limits 10/1/2017 TRUVADA 167 MG-250 MG TABLET Added Quantity Limits 10/1/2017 TRUVADA 200 MG-300 MG TABLET Added Quantity Limits 10/1/2017 ultimate ob dha combo pack Removed from Formulary (Obsolete Drug) 10/1/2017 VERZENIO 100 MG TABLET Added to Formulary (BRAND) with Prior Authorization and Q 12/1/2017 VERZENIO 150 MG TABLET Added to Formulary (BRAND) with Prior Authorization and Q 12/1/2017 VERZENIO 200 MG TABLET Added to Formulary (BRAND) with Prior Authorization and Q 12/1/2017 VERZENIO 50 MG TABLET Added to Formulary (BRAND) with Prior Authorization and Q 12/1/2017 VIDEX 2 GM PEDIATRIC SOLN Added Quantity Limits 10/1/2017 vinacal prenatal tablet Removed from Formulary (Obsolete Drug) 12/1/2017 vinate gt tablet Removed from Formulary (Obsolete Drug) 12/1/2017 vinate pn care tablet Removed from Formulary (Obsolete Drug) 12/1/2017 vinate ultra tablet Removed from Formulary (Obsolete Drug) 12/1/2017 VIRACEPT 250 MG TABLET Added Quantity Limits 10/1/2017 VIRACEPT 625 MG TABLET Added Quantity Limits 10/1/2017 VIREAD 150 MG TABLET Added Quantity Limits 10/1/2017 VIREAD 200 MG TABLET Added Quantity Limits 10/1/2017 VIREAD 250 MG TABLET Added Quantity Limits 10/1/2017 VIREAD 300 MG TABLET Added Quantity Limits 10/1/2017 VIREAD POWDER Added Quantity Limits 10/1/2017 vitafol-pn caplet Removed from Formulary (Obsolete Drug) 10/1/2017 VITAMAX TABLET CHEWABLE Removed from Formulary (Obsolete Drug) 10/1/2017 westhroid mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 westhroid mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 xolox mg tablet Removed from Formulary (Obsolete Drug) 10/1/2017 ZETIA 10 MG TABLET Removed from Formulary (Generic Available) 10/1/2017 zflex tablet Removed from Formulary (Obsolete Drug) 10/1/2017

7 zgesic tablet Removed from Formulary (Obsolete Drug) 10/1/2017 ZIAGEN 20 MG/ML SOLUTION Added Quantity Limits 10/1/2017 ZIAGEN 300 MG TABLET Added Quantity Limits 10/1/2017 zidovudine 100 mg capsule Added Quantity Limits 10/1/2017 zidovudine 300 mg tablet Added Quantity Limits 10/1/2017 zidovudine 50 mg/5 ml syrup Added Quantity Limits 10/1/2017 zinc sulfate 220 mg capsule Removed from Formulary (Obsolete Drug) 10/1/2017

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/

More information

HIV Drugs and the HIV Lifecycle

HIV Drugs and the HIV Lifecycle HIV Drugs and the HIV Lifecycle Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject All HIV drugs work by interrupting different steps in HIV's

More information

May 2016 P & T Updates

May 2016 P & T Updates Commercial Triple Tier 4th Tier Applicabl e Traditional Detailed s 2 films - DESCOVY 2 2 1 tablet NARCAN 2 2 ODEFSEY 2 2 1 tablet REPATHA 2 2 HoFH: 3 ml per 28 ROSUVASTATIN 1 1 - UPTRAVI 3 2 - Alternatives

More information

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION A1. PARTICIPANT ID: ENTER NUMBER HERE - - - ONLY IF ID LABEL IS NOT AVAILABLE A2. VISIT #: A3. VERSION DATE: 1 0 /

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10

More information

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core

More information

Antiretrovial Crushable/Liquid Formulation Chart

Antiretrovial Crushable/Liquid Formulation Chart Antiretrovial Crushable/Liquid Formulation Chart Eliza Dollard, PharmD; Nafeesa Chin-Beckford, PharmD; Laura Aragon, PharmD Last Updated: 04/2016 Agent How Supplied Crushable Status **Products listed in

More information

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM ID LABEL HERE ---> VERSION DATE 10/01/07 - - - VISIT #: FORM COMPLETED BY: A1. DATE OF BLOOD DRAW: / / M D Y A2. Do you take

More information

Appropriate Use & Safety Edits

Appropriate Use & Safety Edits Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely

More information

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL Generic Name COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir)

More information

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir

More information

Emblem Medicaid 3Q18 Formulary Updates

Emblem Medicaid 3Q18 Formulary Updates ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from

More information

ANTIRETROVIRAL TREATMENTS (Part 1of

ANTIRETROVIRAL TREATMENTS (Part 1of CCR5 CO-RECEPTOR ANTAGONISTS maraviroc (MVC) Selzentry 25mg, 75mg, FUSION INHIBITORS 20mg/mL ANTIRETROVIRAL TREATMENTS (Part 1of 5) oral soln enfuvirtide (ENF, T-20) Fuzeon 90mg/mL pwd for SC inj after

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir) Stavudine

More information

Antiretroviral Dosing in Renal Impairment

Antiretroviral Dosing in Renal Impairment Protease Inhibitors (PIs) Atazanavir Reyataz hard capsules 300 mg once daily taken with ritonavir 100 mg once daily No dosage adjustment is needed for atazanavir in renal impairment Atazanavir use in haemodialysis

More information

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.

More information

Midwestern Underwriting Conference 2016

Midwestern Underwriting Conference 2016 UNDERWRITING HIV: THE FAIRY TALE HAS BECOME REALITY Midwestern Underwriting Conference 2016 Jean-Marc Fix, FSA, MAAA VP, R&D, Optimum Re Insurance Co. AGENDA Where are we with HIV? The risk The ideal case

More information

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO Ont. Drug Distr. Ontario Drug Benefit/Trillium: Other Formulary (F/A) Limited Use (Section 16) Antiretrovirals AZT 100 mg capsules NRTIs (single): Abacavir,

More information

FLORIDA!A MEDICAID' Better Health Care for all Floridians. May

FLORIDA!A MEDICAID' Better Health Care for all Floridians. May CHARLIE CRIST GOVERNOR FLORIDA!A MEDICAID' Better Health Care for all Floridians HOllY BENSON SECRETARY May 26. 2009 Policy Transmittal: HMO 09-01 Policy Transmittal: PS 09-01 RE: Year Thrcc PerFormance

More information

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA).

More information

HIV medications HIV medication and schedule plan

HIV medications HIV medication and schedule plan Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider update Quarterly pharmacy formulary change notice Summary: The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018, Pharmacy and Therapeutics Committee

More information

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change Medi-Cal Managed Care L. A. Care Major Risk Medical Insurance Program Provider Bulletin The formulary changes listed in the table below were reviewed and approved at our first-quarter 2018 Pharmacy and

More information

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care www.nwaetc.org The Northwest AIDS Education and Training Center (NW AETC), located at the University

More information

2018 Formulary Notice of Change Prescription Drug Plans

2018 Formulary Notice of Change Prescription Drug Plans 2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the

More information

Page 1 of 5 ENLGLISH / ESPAÑOL / PORTUGUÉS / FRANÇAIS Share 3 Drug Chart for HIV Treatment CURRENT EDITION ABOUT SENSE BACK ISSUES MSMGF HOME CONTACT US There are a number of antiretroviral (ARV) medications

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: Effective August 1, 2018, the preferred formulary changes detailed in the table below will apply to District of Columbia Healthy Families

More information

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options STRATEGIES FOR THIRD LINE HIV THERAPY issues to consider when faced with few drug options A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Most people living

More information

Cystic Fibrosis Agents

Cystic Fibrosis Agents Texas Prior Authorization Program Clinical Criteria Clinical Information Included in this Document Kalydeco (Ivacaftor) Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Cystic Fibrosis Agents

Cystic Fibrosis Agents Texas Prior Authorization Program Clinical Criteria Clinical Information Included in this Document Kalydeco (Ivacaftor) Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

The ART of Antiretroviral Therapy in Critically-ill Patients with HIV

The ART of Antiretroviral Therapy in Critically-ill Patients with HIV The ART of Antiretroviral Therapy in Critically-ill Patients with HIV Tyler Finocchio, PharmD, BCPS PGY2 Critical Care Pharmacy Resident Avera McKennan Hospital & University Health Center February 10 th,

More information

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications Carrie Allen PharmD, CGP, BCPS, BCPP, CCHP Overview - Part 2: HIV

More information

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection Table 3. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Generic Name (Abbreviation) / Trade Name Abacavir (ABC) / Ziagen Trizivir with ZDV + 3TC Epzicom with 3TC Didanosine (ddi)

More information

HIV Infection & AIDS in Low- and Middle-Income Countries

HIV Infection & AIDS in Low- and Middle-Income Countries GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 25: HIV Infection & AIDS in Low- and Middle-Income Countries Author P. Van de Perre, MD, PhD Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues

More information

MEDICATION RELATED ISSUES IN THE HIV PATIENT. LEONARD SOWAH, MBChB, MPH, FACP

MEDICATION RELATED ISSUES IN THE HIV PATIENT. LEONARD SOWAH, MBChB, MPH, FACP MEDICATION RELATED ISSUES IN THE HIV PATIENT LEONARD SOWAH, MBChB, MPH, FACP Overview Evalua;on and ini;al of a HIV pa;ent with respect to medica;ons Triaging of pa;ent to determine ideal follow up plan

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic

More information

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs

More information

Topical Immunomodulators

Topical Immunomodulators Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Topical Immunomodulators Clinical Edit Information Included in this Document Topical Immunomodulators Elidel and Protopic 0.03%

More information

Agents for Cystic Fibrosis

Agents for Cystic Fibrosis Texas Prior Authorization Program Clinical Edit Criteria Clinical Edit Information Included in this Document Kalydeco (Ivacaftor) Drugs requiring prior authorization: the list of drugs requiring prior

More information

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010 AIDS Drug Assistance Program ADAP-Miami NEEDS ASSESSMENT July 16, 2010 ADAP Clients - Gender ADAP Clients by Gender FY 09/10 April 2010 to June 2010 26% 0% Males Females 26% 0% Males Females Transgender

More information

Health Partners Medicare Special 2018 Formulary Changes

Health Partners Medicare Special 2018 Formulary Changes Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.

More information

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search Search 1 :When to Initiate ART Covers Questions 1-5 including to prevent transmission Component Description Review area Objectives

More information

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen

More information

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION OB/GYN CHART REVIEW A summary of OB/GYN clinical chart review results designed to monitor the quality of care provided by a Ryan White funded OB/GYN primary care site as part of the Atlanta EMA s quality

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN March 2019 Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at the fourth quarter pharmacy and therapeutics

More information

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin October 2018 Quarterly pharmacy formulary change notice The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. The changes listed in the table

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at our second quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE: FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

2018 CareOregon Advantage Part D Formulary Changes

2018 CareOregon Advantage Part D Formulary Changes 2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse

HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),

More information

2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST

2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST 2018 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy Drug Name Strength Dosage Form 80mg-160mg,

More information

ABRIDGED ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

ABRIDGED ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL NULOESIDE/TIDE REVERSE TRANSRIPTASE INHIBITORS (N(t)RTIs) Abacavir AB (Ziagen) Emtricitabine FT (Emtriva) Lamivudine 3T (Epivir) Tenofovir disoproxil fumarate TDF (Viread) Zidovudine AZT, ZDV (Retrovir)

More information

2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST

2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST 2019 CHP+/MEDICAID CHOICE OVER-THE-COUNTER (OTC) LIST Note: Prescriptions for OTCs must be written by a Denver Health provider and filled at a Denver Health Pharmacy ACETAMINOPHEN ALCOHOL ANTISEPTIC PADS

More information

ICP Formulary Updates

ICP Formulary Updates ICP Formulary Updates July 2017 TRADE NAME (generic name) adapalene cream 0.1% 2017-07-01 Removal adapalene gel 0.3% 2017-07-01 Removal adefovir dipivoxil tab 10 mg 2017-07-01 Removal ADVAIR DISKUS (fluticasone-salmeterol

More information

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920 0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN October 2018 The formulary changes listed in the table below were reviewed and approved at the second-quarter 2018 Pharmacy and Therapeutics Committee meeting. Effective October

More information

BlueLink TPA FlexRx Updates

BlueLink TPA FlexRx Updates BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%

More information

HIV and YOU. Special 2008 Update!

HIV and YOU. Special 2008 Update! HIV and YOU Special 2008 Update! HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND

More information

HIV Management Update 2015

HIV Management Update 2015 9/30/15 HIV Management Update 2015 Larry Pineda, PharmD, PhC, BCPS Visiting Assistant Professor Pharmacy Practice and Administrative Science ljpineda@salud.unm.edu Pharmacist Learning Objectives Describe

More information

FORMULARY LIST OF COVERED DRUGS

FORMULARY LIST OF COVERED DRUGS FORMULARY LIST OF COVERED DRUGS 2018 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00018248, Version Number #3 This formulary

More information

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist An HIV Update - 2019 Jan Clark, PharmD Specialty Practice Pharmacist 2 The goal of this program is to provide a review and update of HIV care and to provide a forum for discussing the current local and

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee

More information

Genotyping and Drug Resistance in Clinical Practice. Case Studies

Genotyping and Drug Resistance in Clinical Practice. Case Studies Genotyping and Drug Resistance in Clinical Practice Case Studies 12/02 40 year old Hispanic male Dx with HIV 1995 + Hx of PCP > 1x, HepC Medication history: AZT, Crixivan, Videx EC, Sustiva, Zerit, Ziagen,

More information

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time STRATEGIES FOR FIRST LINE HIV THERAPY issues to think about when going on therapy for the first time A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Deciding

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters

Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline

More information

Nothing to disclose.

Nothing to disclose. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital HIV UPDATE FOR THE PRIMARY CARE PROVIDER Nothing to disclose. 1 Outline Epidemiology Screening / testing for HIV

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

October 26-28: Training Day 1

October 26-28: Training Day 1 Peer Linkage and Re-Engagement of HIV- Positive Women of Color October 26-28: Training Day 1 Peer Linkage and Re -Engagement of HIV - Positive Women of Color Convening Training Trainers Today: Alicia Downes

More information

Drug Treatment Program Update

Drug Treatment Program Update Drug Treatment Program Update As of March 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential

More information

Fluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids

Fluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids Supportive therapy Summary of interactions Table 1. Summary of potential interactions between antiretroviral agents and supportive therapy Interactions with enzyme inhibitors (protease inhibitors and elvitegravir/cobicistat)

More information

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

treatment passport 1

treatment passport 1 treatment passport 1 Why keep a treatment history? Keeping a short record of your treatment history can help in many ways. It can help you understand your health and treatment. It can help if your doctor

More information

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop Parya Saberi, PharmD, MAS The Medical Management of HIV/AIDS December 2012 Objectives What are commonly used ARVs and where do they work in

More information

The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project. ARV Dosing in End Stage Renal Disease

The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project. ARV Dosing in End Stage Renal Disease The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project ARV Dosing in End Stage Renal Disease 1. Jayasekara, D., Aweeka, F. T., Rodriguez, R., Kalayjian, R. C., Humphreys, M. H.,

More information

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary At a Glance: VA ADAP Formulary Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Non Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Multi Class Combination Agents Protease Inhibitors

More information

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs Arkansas Blue Cross and Blue Shield Metallic Formulary 018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to

More information

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs

Arkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to

More information

FORMULARY LIST OF COVERED DRUGS

FORMULARY LIST OF COVERED DRUGS FORMULARY LIST OF COVERED DRUGS 2017 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. HPMS Approved Formulary File Submission ID 00017274, Version Number 6 This formulary

More information

Aetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s)

Aetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on July 1, 2017 ADAPALENE 0.1% CREAM ADAPALENE 0.1% GEL ATORVASTATIN 10

More information

You ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.

You ll find the most up-to-date comprehensive version of our formulary on our website,   Click on Drug Finder. 3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs

More information

Antiretroviral Pregnancy Registry

Antiretroviral Pregnancy Registry Preterm Birth, low birth weight and fetal antiretroviral exposure: Estimated gestational age and birth weight data from singleton live births, 1989 through 31 January 2009 K. Beckerman, J. Albano, M. Martinez-Tristani,

More information

HOW TO USE THE FORMULARY

HOW TO USE THE FORMULARY INTRODUCTION The information contained in the Willamette Valley Community Health (WVCH) WRAP/D-Excluded Formulary and its appendices is provided solely for the convenience of medical providers. WVCH does

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR

More information

A Fatal Imbalance. Tropical diseases: 18 new drugs (incl. 8 for malaria) 1.3% 21 new drugs for neglected diseases. Tuberculosis: 3 new drugs

A Fatal Imbalance. Tropical diseases: 18 new drugs (incl. 8 for malaria) 1.3% 21 new drugs for neglected diseases. Tuberculosis: 3 new drugs ADDRESSING GAPS IN INNOVATION FOR NEGLECTED PATIENTS: DNDI ANDPEDIATRIC HIV/AIDS Rachel Cohen, Regional Executive Director, DNDi North America Proposals for a Global Innovation System that Responds to

More information

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION Added Prior Authorization 7/1/17 CORLANOR 5 MG TABLET Added Prior Authorization 7/1/17 CORLANOR 7.5 MG TABLET Added Prior Authorization 7/1/17

More information

2018 Comprehensive List of Covered Drugs

2018 Comprehensive List of Covered Drugs Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use

More information

continuing education for pharmacists

continuing education for pharmacists continuing education for pharmacists HIV/AIDS: Overview and Resources for Pharmacists Mona T. Thompson, R.Ph., PharmD Volume XXXIII, No. 9 Dr. Mona T. Thompson has no relevant financial relationships to

More information

Approach for the Newly Diagnosed HIV Positive Patient

Approach for the Newly Diagnosed HIV Positive Patient Approach for the Newly Diagnosed HIV Positive Patient Jason E. Farley, PhD, MPH, ANP-BC, FAAN, AACRN Associate Professor & NP, Johns Hopkins University School of Nursing & Medicine Director, AETC Adult-Gerontology

More information

2016 Prescription Drug Guide

2016 Prescription Drug Guide 2016 Prescription Drug Guide Humana Medicare Employer Plan Formulary List of covered drugs Humana Group Medicare Plus 1 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS

More information

Selecting an Initial Antiretroviral Therapy (ART) Regimen

Selecting an Initial Antiretroviral Therapy (ART) Regimen Selecting an Initial Antiretroviral Therapy (ART) Regimen An HIV Diagnosis is a Call to Action In support of the NYSDOH AIDS Institute s January 2018 call to action for patients newly diagnosed with HIV,

More information